Alteration [idcn]
Serum [bdsu]
Levels [qlco]
Metabolic [ftcn]
Body Composition [orga]
Early [tmco]
Breast Cancer [neop]
Patients [podg]
Receive [qlco]
adjuvant therapy [topp]
Endocrine [bdsy]
Background [cnce]
Early [tmco]
Breast Cancer [neop]
Patients [podg]
effects [qlco]
therapy, hormonal [topp]
Tamoxifen [orch, phsu]
Aromatase Inhibitors [phsu]
Plasma [bdsu]
Lipid level [lbtr]
Body Composition [orga]
Not [ftcn]
investigated [ftcn]
Aim [idcn]
To [qlco]
Relationship [qlco]
Body Composition [orga]
effects [qlco]
Tamoxifen [orch, phsu]
Aromatase Inhibitors [phsu]
plasma lipid [lbpr]
Level [qlco]
Body Composition [orga]
Methods [inpr]
Patients [podg]
treated [topp]
Tamoxifen [orch, phsu]
Aromatase Inhibitors [phsu]
Menopausal Status [clna]
Radiotherapy, Adjuvant [topp]
Over [spco]
Body Composition [orga]
serum lipid [lbpr]
Profile [lbpr]
Glucose [bacs, carb, phsu]
Levels [qlco]
Evaluated [ftcn]
Record [inpr]
Type [qlco]
therapy, hormonal [topp]
Body Mass Index [diap]
Waist-to-Hip Ratio [orga]
Lipid [lipd]
Profile [lbpr]
Levels [qlco]
Beginning [tmco]
months [tmco]
Result [ftcn]
statistically significant [qnco]
Decrease [qlco]
Serum [bdsu]
Levels [qlco]
months [tmco]
adjuvant therapy [topp]
Endocrine [bdsy]
pg/mL [qnco]
pg/mL [qnco]
P NOS [aapp, imft]
Total body water [fndg]
P NOS [aapp, imft]
Serum Glucose [lbpr]
P NOS [aapp, imft]
Triglyceride level [lbtr]
P NOS [aapp, imft]
Exhibit [inpr]
Decrease [qlco]
decreases [qnco]
Total Cholesterol [lbpr]
Low density lipoprotein [aapp, bacs, lipd]
Not significant [fndg]
Statistically [ocdi]
High density lipoprotein [aapp, bacs, lipd]
Increased [qnco]
adjuvant therapy [topp]
Endocrine [bdsy]
Not [ftcn]
Reach [orgf]
Statistical Significance [qnco]
Body Composition [orga]
Glucose [bacs, carb, phsu]
Lipid [lipd]
Profile [lbpr]
Similar [qlco]
Tamoxifen [orch, phsu]
Aromatase inhibitor [phsu]
Group [idcn]
Correlation [qlco]
Found [qnco]
Basal [spco]
weight [orga]
Mass [fndg]
Fat-free mass [fndg]
Serum [bdsu]
Levels [qlco]
Correlation [qlco]
Maintained [ftcn]
Only [qnco]
Fat-free mass [fndg]
month [tmco]
Conclusion [idcn]
Part [spco]
Present [qnco]
Study [mnob]
Suggest [idcn]
Tamoxifen [orch, phsu]
Aromatase Inhibitors [phsu]
Levels [qlco]
Compositions, Body [orga]
Drugs [phsu]
Provide [acty]
antihyperlipidemic [phsu]
antidiabetic [phsu]
effects [qlco]
recommend [idcn]
Serum [bdsu]
Level [qlco]
Tumor [neop]
Biomarker [clna]
early-stage breast cancer [neop]
Monitoring [hlca]
purposes [ftcn]
Levels [qlco]
Help [socb]
Physicians [prog]
Estimate [qnco]
Prognosis [hlca]
Further [spco]
studies [lbpr]
larger [qnco]
Population [qnco]
Light [npop]
Role [socb]
Breast Cancer [neop]
